Drugs / active intervention
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04292054 Comparator | Oct 2020 → Apr 2026 overdue | — | Assistance Publique - Hôpitaux de Paris | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | active intervention | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04292054 ↗ |
| Route | Intravenous | “piperacilline-tazobactam 4 g powder for solution for injection diluted in 50mL of NaCl 0.9%, IV infusion on 30 minutes with syringe driver” NCT04292054 ↗ |